Celldex Therapeutics, Inc.CLDXNASDAQ
Loading
EBITDA Margin Over TimeContracting
Percentile Rank0
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
-17028.00%
↓ 415% vs avg
Percentile
P0
Near historical low
Streak
2 yr
Consecutive declineContracting
Average
-3303.98%
Historical baseline
PeriodValueYoY Change
2025-17028.00%-522.9%
2024-2733.63%-35.3%
2023-2019.96%+54.3%
2022-4420.87%-211.2%
2021-1420.77%-130.9%
2020-615.30%+55.7%
2019-1390.06%-82.6%
2018-761.20%+6.7%
2017-816.27%+55.5%
2016-1833.75%-